Many studies are ongoing to address how PHEX loss‐of‐function leads to the biochemical and skeletal abnormalities observed in XLHR with multiple factors continuously being identified, among which FGF23 was a key regulator involved in a bone–kidney axis regulating phosphate homeostasis. Here, FGF23 is linked to X-linked dominant hypophosphatemic rickets.